IBDEI0HV ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24138,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,24138,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,24138,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,24139,0)
 ;;=V17.5^^127^1433^4
 ;;^UTILITY(U,$J,358.3,24139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24139,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,24139,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,24139,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,24140,0)
 ;;=V17.7^^127^1433^3
 ;;^UTILITY(U,$J,358.3,24140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24140,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,24140,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,24140,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,24141,0)
 ;;=V19.0^^127^1433^5
 ;;^UTILITY(U,$J,358.3,24141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24141,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,24141,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,24141,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,24142,0)
 ;;=V16.3^^127^1433^6
 ;;^UTILITY(U,$J,358.3,24142,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24142,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,24142,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,24142,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,24143,0)
 ;;=V16.41^^127^1433^9
 ;;^UTILITY(U,$J,358.3,24143,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24143,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,24143,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,24143,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,24144,0)
 ;;=V16.42^^127^1433^10
 ;;^UTILITY(U,$J,358.3,24144,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24144,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,24144,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,24144,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,24145,0)
 ;;=V16.43^^127^1433^11
 ;;^UTILITY(U,$J,358.3,24145,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24145,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,24145,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,24145,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,24146,0)
 ;;=V19.5^^127^1433^13
 ;;^UTILITY(U,$J,358.3,24146,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24146,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,24146,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,24146,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,24147,0)
 ;;=V19.2^^127^1433^14
 ;;^UTILITY(U,$J,358.3,24147,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24147,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,24147,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,24147,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,24148,0)
 ;;=V17.3^^127^1433^16
 ;;^UTILITY(U,$J,358.3,24148,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24148,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,24148,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,24148,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,24149,0)
 ;;=V16.6^^127^1433^17
 ;;^UTILITY(U,$J,358.3,24149,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24149,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,24149,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,24149,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,24150,0)
 ;;=V18.61^^127^1433^19
 ;;^UTILITY(U,$J,358.3,24150,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24150,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,24150,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,24150,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,24151,0)
 ;;=V17.0^^127^1433^20
 ;;^UTILITY(U,$J,358.3,24151,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24151,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,24151,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,24151,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,24152,0)
 ;;=V19.4^^127^1433^21
 ;;^UTILITY(U,$J,358.3,24152,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24152,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,24152,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,24152,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,24153,0)
 ;;=V17.1^^127^1433^22
 ;;^UTILITY(U,$J,358.3,24153,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24153,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,24153,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,24153,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,24154,0)
 ;;=V16.8^^127^1433^12
 ;;^UTILITY(U,$J,358.3,24154,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24154,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,24154,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,24154,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,24155,0)
 ;;=V11.1^^127^1433^24
 ;;^UTILITY(U,$J,358.3,24155,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24155,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,24155,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,24155,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,24156,0)
 ;;=V15.89^^127^1433^46
 ;;^UTILITY(U,$J,358.3,24156,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24156,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,24156,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,24156,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,24157,0)
 ;;=V11.3^^127^1433^25
 ;;^UTILITY(U,$J,358.3,24157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24157,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,24157,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,24157,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,24158,0)
 ;;=V15.07^^127^1433^26
 ;;^UTILITY(U,$J,358.3,24158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24158,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,24158,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,24158,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,24159,0)
 ;;=V13.4^^127^1433^27
 ;;^UTILITY(U,$J,358.3,24159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24159,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,24159,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,24159,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,24160,0)
 ;;=V12.72^^127^1433^31
 ;;^UTILITY(U,$J,358.3,24160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24160,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,24160,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,24160,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,24161,0)
 ;;=V12.59^^127^1433^30
 ;;^UTILITY(U,$J,358.3,24161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24161,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,24161,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,24161,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,24162,0)
 ;;=V45.81^^127^1433^29
 ;;^UTILITY(U,$J,358.3,24162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24162,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,24162,1,5,0)
 ;;=5^Hx of CABG
 ;;^UTILITY(U,$J,358.3,24162,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,24163,0)
 ;;=V15.84^^127^1433^28
 ;;^UTILITY(U,$J,358.3,24163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24163,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,24163,1,5,0)
 ;;=5^Hx of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,24163,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,24164,0)
 ;;=V15.85^^127^1433^47
 ;;^UTILITY(U,$J,358.3,24164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24164,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,24164,1,5,0)
 ;;=5^Hx of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,24164,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,24165,0)
 ;;=V10.72^^127^1433^34
 ;;^UTILITY(U,$J,358.3,24165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24165,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,24165,1,5,0)
 ;;=5^Hx of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,24165,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,24166,0)
 ;;=V15.3^^127^1433^35
 ;;^UTILITY(U,$J,358.3,24166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24166,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,24166,1,5,0)
 ;;=5^Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,24166,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,24167,0)
 ;;=V10.61^^127^1433^37
 ;;^UTILITY(U,$J,358.3,24167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24167,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,24167,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,24167,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,24168,0)
 ;;=V12.03^^127^1433^39
 ;;^UTILITY(U,$J,358.3,24168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24168,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,24168,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,24168,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,24169,0)
 ;;=V10.82^^127^1433^40
 ;;^UTILITY(U,$J,358.3,24169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24169,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,24169,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,24169,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,24170,0)
 ;;=V10.62^^127^1433^43
 ;;^UTILITY(U,$J,358.3,24170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24170,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,24170,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,24170,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,24171,0)
 ;;=V10.63^^127^1433^41
 ;;^UTILITY(U,$J,358.3,24171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24171,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,24171,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,24171,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,24172,0)
 ;;=V11.2^^127^1433^32
 ;;^UTILITY(U,$J,358.3,24172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24172,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,24172,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,24172,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,24173,0)
 ;;=V15.81^^127^1433^60
 ;;^UTILITY(U,$J,358.3,24173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24173,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,24173,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,24173,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,24174,0)
 ;;=V10.43^^127^1433^44
 ;;^UTILITY(U,$J,358.3,24174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24174,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,24174,1,5,0)
 ;;=5^Hx of Ovarian CA
